Background. The pathogenesis of salt and water accumulation in patients with chronic obstructive pulmonary disease is unclear and may differ from that in patients with congestive heart failure due to myocardial disease. This study was undertaken to investigate some of the mechanisms involved.
Methods and Results. Hemodynamics, water and electrolyte spaces, renal function, and plasma hormone concentrations were measured in nine patients with edema due to chronic obstructive pulmonary disease and in six patients after recovery. Mean cardiac output (3.8±0.26 I/min m 2) was normal, but right atrial (11± 1 mm Hg) and mean pulmonary arterial (41±3 mm Hg) pressures were increased. Mean pulmonary arterial wedge pressure (11±1 mm Hg) was normal. Pulmonary vascular resistance (8.6±1.3 mm Hg. min m2/l) was increased, but systemic vascular resistance (19.3+1.3 mm Hg. min * m2/l) and mean arterial pressure (83+±4 mm Hg) were low. All patients were hypoxemic (Pao2, 40±2 mm Hg) and hypercapnic (Paco2, 60±2 mmHg). There was a significant increase in total body water (+21%), extracellular volume (+45%), plasma volume (+45%), blood volume (+88%), and exchangeable sodium (+38.2%). Renal plasma flow was severely reduced (-63.2%), but glomerular filtration rate was only mildly decreased (-32%). Significant increases were seen in plasma norepinephrine (3.5-fold normal), renin activity (7.6-fold normal), vasopressin (twice normal), atrial natriuretic peptide (9.4-fold normal), growth hormone (10.7-fold normal), and cortisol (1.9-fold normal). After recovery, the Pao2 increased (50±3 mm Hg) and Paco2 fell (45 +4 mm Hg), and the patients became free from edema. All the body compartments returned toward normal, although they did not entirely reach normal values. Renal plasma flow increased significantly, and glomerular filtration became normal. Right atrial and pulmonary arterial pressures and pulmonary vascular resistance decreased (p<0.01). Cardiac output decreased but not significantly. Blood pressure increased but not significantly. However, systemic vascular resistance increased significantly to a normal value.
Conclusions. We conclude that patients with edema due to chronic obstructive pulmonary disease have severe retention of salt and water, reduction in renal blood flow and glomerular filtration, and neurohormonal activation similar to that seen in patients with edema due to myocardial disease. However, unlike the latter, in chronic obstructive pulmonary disease cardiac output is normal, and systemic vascular resistance and arterial blood pressure are low. This probably is due to the vasodilator properties of hypercapnia. The consequent low arterial blood pressure may be the stimulus for the neurohormonal activation and retention of salt and water. (Circulation 1992;86: [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] KEY WoRDs * chronic obstructive pulmonary disease * congestive heart failure * extracellular volume * cor pulmonale * sodium * edema * renal blood flow * hormones, plasma In the natural history of chronic bronchitis and edema in congestive heart failure due to low output emphysema, certain patients accumulate salt and states have now been recognized,1-4 the pathogenesis of water. Clinicians recognize this syndrome as cor edema in chronic obstructive pulmonary disease repulmonale and often refer to it as right heart failure. mains unclear.5-9 Some believe that a failing right Although the mechanisms involved in the production of ventricle contributes to the genesis of edema in chronic obstructive pulmonary disease. However, even during periods of edema, hemodynamic measurements in pa-tients with chronic obstructive pulmonary disease reveal cardiac output that is normal or at the upper limit of normal.'0'11 Furthermore, right and left ventricular functions are normal at rest and during exercise. [12] [13] [14] There is, therefore, little evidence to suggest myocardial dysfunction as a cause of edema in chronic obstructive pulmonary disease.
Edema in low output states is associated with neurohormonal activation and reduction of renal blood flow. 34"15-'8 In this article, we present data on water and sodium spaces, renal function, hemodynamics, and plasma hormones in nine patients with edema due to chronic obstructive pulmonary disease. Six patients were restudied after recovery.
Methods

Patients
The studies were carried out in nine consecutive patients (age, 45.7+2.5 years; body surface area, 1.45 ±0.06 m2; seven women and two men) with chronic obstructive pulmonary disease who presented with clinical evidence of chest infection and acute respiratory failure and had developed fluid retention. All patients had long-standing chronic obstructive pulmonary disease and were regularly followed in the chest clinic. None had any other cause to account for edema. Six patients were restudied after resolution of systemic congestion (average, 3 weeks later). On admission, all patients had peripheral edema, and three had ascites. Body weight was 50.4±6.0 kg. Mean jugular venous pressure was elevated (11±0.6 cm), and the liver was enlarged (5±0.6 cm). A right ventricular third sound was heard in all, and a tricuspid regurgitation murmur was heard in five. Blood gases showed severe hypoxia (Pao2, 40±2 mm Hg; systemic oxygen saturation, 76±2%), hypercapnia (Paco2, 60±2 mm Hg), and a compensated respiratory acidosis (serum bicarbonate, 37±2 meq/l; pH 7.4). Forced expiratory volume in 1 second (FEV,) was 0.68+0.06 1, and FEV1/VC (vital capacity) was 42.6±3%. Chest radiographs showed mild cardiomegaly (cardiothoracic ratio, 57.3+8.8%). All patients had been treated for a prolonged time with the following drugs at home: aminophyllin (600 mg daily), salbutamol (12 mg daily), and furosemide (seven patients received 40 mg daily, patient 4 received 80 mg daily, and patient 6 received none). Patients 2, 5, and 7 were also receiving medroxy progesterone (30 mg daily), and patient 4 was receiving prednisolone (60 mg daily). Throughout their hospital stay, they continued to receive the same dosages of these drugs. In particular, no change was made in their diuretic therapy. The only alterations made to their treatment were the addition of antibiotics, regular physiotherapy, and institution of 24% oxygen through a ventimask. Normal hospital diet was allowed.
Protocol
The patients were studied on two occasions; each study lasted 2 days. Hormone estimation and hemodynamic measurements were made on the first day and body fluid compartments and renal blood flow measurements on the second day. The first study was made within 2 days of admission while the patients were in most signs and symptoms of acute exacerbation of the obstructive pulmonary disease and systemic congestion had subsided (average, 3 weeks later). During both studies, patients continued to receive the same drug therapy.
Hemodynamics and Echocardiography
Hemodynamics were measured with a Swan-Ganz thermodilution catheter introduced through either the left subclavian vein or the femoral vein. A cannula was inserted into the radial or brachial artery for measurement of arterial blood pressure and for blood gas analysis. Cardiac output was measured in triplicate by thermodilution (Gould SP 1445 monitor). The ECG, heart rate, and pulmonary artery, pulmonary artery wedge, right atrial, and systemic arterial pressures were measured using quartz transducers (Hewlett-Packard model 1290C) and a Hewlett-Packard patient monitor (model 78354A). After instrumentation, patients were allowed to rest in bed, and oxygen therapy was stopped for at least 1 hour before measurements. Arterial blood gases were analyzed on room air with an ABL-2 blood gas analyzer (Radiometer, Copenhagen). M-mode and two-dimensional echocardiographic measurements were made using a Diasonics V3400 (Diasonics Malpitas) or an ATL Ultramark 8 (Advanced Technology Laboratories, Bothell, Wash.) equipment. M-mode measurements were made with the patient in the supine position using the standard criteria of the American Society of Echocardiography. Water and Sodium Spaces and Renal Function Body water, sodium spaces, and renal function were measured with standard isotope dilution techniques as described previously.3"9 Briefly, plasma volume was calculated from the volume of distribution of 5 ,uCi "SI-labeled human serum albumin 10 minutes after intravenous injection. Extracellular volume and glomerular filtration rate were measured simultaneously with 100 ,uCi`1Cr-labeled EDTA and calculated by numerical analysis. Effective renal plasma flow was estimated with 100 ,Ci "'I-labeled sodium iodohippurate and calculated by numerical analysis. Total body water was measured with 100 ,Ci tritiated water, and total body exchangeable sodium was measured with 20 ,uCi 22Na administered orally. The protocol allowed all measurements to be made in a single 24-hour period. 3"19 
Plasma Hormones
Plasma hormone assays were done on a 30-ml sample of blood drawn from a forearm vein before the start of the hemodynamic study, as described previously.3,20 Briefly, for the assay of catecholamines and renin activity, blood was collected into chilled tubes containing 1 mg/ml EDTA, whereas samples for measurement of atrial natriuretic peptide were collected in chilled tubes containing 1 mg/ml EDTA and 400 units/ml aprotinin. The assays of aldosterone, vasopressin, cortisol, growth hormone, and prolactin were done on serum. All the samples were centrifuged immediately. Those for catecholamine determination were stored at -70°C; all other samples were lyophylized. Plasma epinephrine and norepinephrine were measured by high-performance liquid chromatography with electrochemical detection. Plasma renin activity, aldosterone, cortisol, prolactin, growth hormone, vasopres-respiratory failure. Six patients were restudied after sin, and atrial natriuretic peptide were measured by radioimmunoassay.
Comparison of Findings With Those in Patients With Edema From Myocardial Disease
The hemodynamics, water and sodium spaces, renal function, and plasma hormone data were compared with those obtained previously3 in eight patients with severe untreated congestive heart failure (four men and four women; age, 46±6 years). All patients had increased jugular venous pressure, ankle edema, and hepatomegaly, and five had ascites. Congestive heart failure was due to coronary artery disease in two and cardiomyopathy in six.
Statistical Analysis
All data are expressed as mean+SEM. Significance of changes in various parameters within groups was assessed by Student's paired t test. In addition, we compared the data on patients with chronic obstructive pulmonary disease with those for normal controls3,21 and for patients with congestive heart failure.3 For these comparisons, the unpaired t test was used. A value of p<0.05 was considered significant. The study was performed after obtaining written informed consent from the patients and was approved by the institute's ethics committee.
Results
Hemodynamics, water and sodium spaces, renal function, and plasma hormones in the patients during the first study are given in Tables 1-3 and in Figure 1 . In these tables and the figure, our previously published data from normal subjects3,21 and from patients with edema due to severe myocardial disease,3 obtained using identical methods, are included for purposes of comparison.
ECGs and Echocardiograms
All patients except one had right-axis deviation (frontal plane axis, >900) in the ECG. Four patients had R/S amplitude ratio in lead V, >1. There was P pulmonale in three patients, and clockwise rotation of the heart occurred in four patients. One patient had a completely normal ECG. Satisfactory echocardiographic measurements were made in only seven patients. The left ventricle was small in size with internal dimensions of 3.7+0.07 cm in diastole and 2.5+0.13 cm in systole. The left ventricular contractility was normal. The right ventricle was enlarged, and the internal dimension, measured at end diastole, was 2.8+0.19 cm. Echo Doppler examination was available only in the last three patients (patients 7-9). All showed moderate tricuspid regurgitation with calculated right ventricular systolic pressures of 66, 72, and 74 mm Hg, respectively. The right ventricular thickness could not be assessed accurately. Ventricular volume measurements were not made, and right ventricular function was not assessed.
Pulmonary Function Tests
FEV1 (0.68+0.06 1) and FVC (1.58+0.07 1) were reduced significantly. The ratio of FEVL/FVC was only
Hemodynamics and Arterial Blood Gases
During the acute exacerbation of chronic obstructive lung disease and systemic congestion, all patients had resting tachycardia. Average cardiac output (3.8±0. 26 1/min m2) was normal. Mean pulmonary artery pressure was raised moderately. Right atrial pressure was raised, but pulmonary arterial wedge pressure was normal. Mean systemic arterial pressure was lower than normal (p<O.Ol). There was a moderate increase in the pulmonary vascular resistance (8.6±1.3 mm Hg * min m'/1), but systemic vascular resistance (19.3+1.3 mm Hg * min m2/1) was significantly lower than that in our normal subjects (p<0.01).21 Arterial blood gases showed severe hypoxemia (Pao2, 40+ 2.2 mm Hg; 02 saturation, 76+±2%) and hypercapnia (Paco2, 60+2 mm Hg). pH was 7.4±0.01, and serum bicarbonate was 37±2 meq/l ( Table 1 and Figure 1 ).
Water and Sodium Spaces and Renal Function
All body fluid compartments were greatly increased. Total body water increased 21% above normal (p<0.01), and the increase was accommodated almost entirely in the extracellular space; the former expanded by 113 ml/kg and the latter by 106 ml/kg. There was no significant change in intracellular volume. The increase in extracellular space was divided between the extravascular and intravascular compartments in proportion to their normal distribution; both the total extracellular volume and the plasma volume increased by 45%. Total blood volume increased by a much greater amount than the plasma volume (87% compared with 45%) because of a 37% increase in hematocrit. Total body exchangeable sodium increased by 38%, and renal plasma flow was severely diminished, averaging 37% of normal values. Glomerular filtration was decreased to a lesser extent, averaging 68% of normal values ( Table 2 and Figure 1 ). Thus, average filtration fraction increased from 0.21 to 0.38. Serum sodium was reduced (133±1.3 mmol/l, p<0.005). However, serum potassium, urea, and creatinine were within normal limits.
Plasma Hormones
The plasma concentration of norepinephrine was increased in every patient, with the average 3.5-fold that of normal (p<0.01). Plasma epinephrine was increased in some patients, but the average was not significantly different from normal values. Plasma renin activity varied greatly; it was within the normal range in five patients and raised in the remaining four. The mean value for renin activity was 7.6-fold that of normal (p<0.01). Serum aldosterone also varied a great deal and was increased only modestly in most patients. In one patient it was extremely high. The average value, however, was not significantly different from normal. Plasma concentration of atrial natriuretic peptide was increased in every patient, with the average 9.4-fold normal (p<0.001). Vasopressin levels were nearly twice normal levels (p<0.05) despite hyponatremia. Growth hormone increased ninefold above normal (p<0.01). Prolactin levels were normal. Cortisol was increased in all except one (who was being treated with prednisolone), and the average was 1.9-fold normal 42.6+3%.
(P<0.001) ( Table 3 Congestive heart failure and normal data are from Reference 3.
Effect of Treatment
Most patients showed improvement in symptoms and regression of systemic venous congestion after the addition of antibiotics, physiotherapy, and oxygen to the treatment they were already receiving. All patients were receiving diuretics and bronchodilators before admis-sion to the hospital, and no change was made in diuretic therapy. One patient required ventilator support (patient 5). Six patients were restudied (average, 3 weeks later) before being discharged. One patient (patient 9) had only hemodynamic measurements repeated; the results are shown in Table 4 . Hemodynamics and arterial blood gases. After treatment, heart rate did not change significantly. Right atrial and pulmonary arterial pressures fell significantly (p<0.01). Pulmonary artery wedge pressure, which was within the normal range in the first study, fell significantly (p<0.05). Pulmonary vascular resistance fell, but this was not statistically significant. Cardiac output fell in five patients and increased in one; mean cardiac output fell from 4.1 to 3.6 1/min* m2 (p=0.056). Systemic vascular resistance increased to normal levels in every patient; the average increase was 23% (p<0.05). There was significant improvement in arterial blood gases, but the patients remained hypoxemic and mildly hypercapnic ( Table 4 ).
Echocardiography. After treatment, there was a small but significant decrease in left ventricular internal dimension in diastole from 3.7±0.07 to 3.6+0.14 cm (p<0.05). Left ventricular systolic diameter also decreased but not significantly (2.5+0.33 to 2.32±0.29 cm, p=0.06). Although right ventricular diameter decreased in every patient after treatment, the effect did not reach a level of significance (2.8±0.19 to 2.6+0.14 cm, p=0.063).
Water and sodium spaces and renal function. Clinical improvement was associated with a substantial and significant decrease in the extracellular, plasma, and blood volumes and in total body water and exchangeable sodium. However, none of these measurements returned completely to normal levels. Glomerular filtration rate increased significantly (p<0.01) and returned to normal. Effective renal plasma flow also increased significantly but remained below normal (Table 4 ).
Plasma hormones. Treatment resulted in a decrease in plasma norepinephrine in three patients, no change in one, and a nearly threefold increase in one. The considerable increase in plasma norepinephrine level in one patient resulted in the mean norepinephrine level being higher than the pretreatment level. Epinephrine levels fell significantly (p<0.05). Plasma renin activity increased in four patients and fell in one. Aldosterone increased substantially in four patients who had normal or modest elevation before treatment but fell in the patient who had the highest pretreatment level. In all patients, the posttreatment level was significantly higher than normal. Plasma atrial natriuretic peptide fell in every patient, but the mean concentration did not return to normal. An inverse correlation (r=0.75 by Spearman's rank) was shown to exist between the fall in atrial natriuretic peptide concentration and the increase in serum aldosterone after clinical improvement. There was no significant change in the plasma concentration of vasopressin, cortisol, growth hormone, or prolactin.
Discussion
Comparison of Findings in Chronic Obstructive Pulmonary Disease Patients With Those in Normal Subjects
We investigated patients with chronic obstructive pulmonary disease who were being treated with diuretics and bronchodilators and were admitted in respiratory failure with edema after a respiratory infection. No change was made in their diuretic therapy, but their infection was actively treated and they were given oxygen. Measurements confirmed that these patients had retained substantial quantities of sodium and water. On average, they had accumulated 5.6 1 of excess water and 860 mmol Na. Excess water was retained almost entirely within the extracellular space, and the intracellular space was not affected. The proportional increase in blood volume was greater than that of plasma volume because of an increase in hematocrit. These findings are similar to most reports in the literature2223 but are unlike those of Campbell et al,6 who found no increase in total body water, a redistribution of fluid from intracellular to extracellular space, and no increase in total body sodium. Despite normal cardiac output, renal blood flow was severely diminished, averaging 36% normal. Glomerular filtration rate was relatively preserved. The reduction in renal function seen in our patients is similar to the observations reported in the literature.24-30 Measurement of the hemodynamics confirmed the presence of moderate pulmonary hypertension, increase in pulmonary vascular resistance, and normal cardiac output, shown previously in patients with respiratory failure and peripheral edema.10-'2 The presence of a reduced systemic vascular resistance, significant in our patients and obvious to the clinician in the form of warm extremities, has not been emphasized in the literature. Arterial blood pressure also was reduced significantly in our patients.
The hormonal response consisted of an increase in plasma norepinephrine and stimulation of the reninangiotensin-aldosterone system similar to that de-scribed by others. 11, 30 The increases in atrial natriuretic peptide and vasopressin seen in our patients also have been reported.30-32 Farber et a130 showed in similar patients that there was an increase in plasma renin activity that correlated with an inability to excrete sodium and an increase in vasopressin relative to plasma osmolality that correlated with an inability to excrete water. An increase in growth hormone, similar to our findings in patients with untreated congestive heart failure and constrictive pericarditis,3,4 has not been reported previously in patients with chronic obstructive pulmonary disease. The significance of this finding remains unclear. Like the increase in cortisol, an increase in growth hormone might reflect a nonspecific response of the body to stress.
Comparison of Findings in Chronic Obstructive Pulmonary Disease Patients With Those in Patients With Edema From Myocardial Disease
The congestive state in patients with edema from chronic obstructive pulmonary disease is similar to that seen in patients with edema due to myocardial disease; but the mechanism responsible for the retention of salt and water in the two conditions may be different. We therefore compared findings in patients with chronic obstructive pulmonary disease with those seen in patients with edema from myocardial disease. To facilitate this comparison, we have included the mean values, obtained using similar methods, from our previous study3 in Tables 1-3 and Figure 1 .
Heart rate, right atrial and pulmonary arterial pressures, and pulmonary vascular resistance were similar in both conditions. Pulmonary artery wedge pressure was normal in patients with chronic obstructive pulmonary disease but significantly increased in patients with edema from myocardial disease, who had damaged left ventricles. The most striking difference between the two conditions was in the systemic circulation. Cardiac output was normal in chronic obstructive pulmonary disease and low in congestive heart failure, and although congestive heart failure patients could maintain normal arterial blood pressure through increased systemic vascular resistance, patients with chronic obstructive pulmonary disease had systemic vasodilatation and could not maintain normal blood pressure. If the heart were normal, such a degree of vasodilatation would have led to greatly increased cardiac output. The fact that cardiac output was not higher than normal in our patients implies a limitation in the pumping capacity of the heart. The limitation must be presumed to lie in the right ventricle where the afterload is increased: An; increased sympathetic drive, right ventricular dimensions, and filling pressures were unable to increase the cardiac output above normal. The right ventricle accommodates poorly to rapid increases in afterload. This may be seen to an extreme degree in massive pulmonary embolism but presumably exists to an extent in the short-term increase in pulmonary vascular resistance that accompanies respiratory infection in patients with chronic obstructive pulmonary disease. The plasma hormone response was similar in both conditions, except vasopressin, which was significantly higher in patients with chronic obstructive pulmonary disease. Although the patients with chronic obstructive pulmonary disease had received furosemide, we have shown else-where33 that a similar low dosage of furosemide (40 mg daily) in patients with severe untreated congestive heart failure and considerable fluid retention had no significant effect on plasma renin activity and aldosterone. Thus, despite evidence of increased sympathetic activity and stimulation of the renin-angiotensin-aldosterone axis in patients with chronic obstructive pulmonary disease similar to that seen in patients with congestive heart failure, systemic vascular resistance is reduced.
Although there were striking differences in the hemodynamics of the two conditions, the changes in the water and electrolyte spaces were similar. Renal plasma flow and glomerular filtration rate also were reduced to similar extent. Although total systemic vascular resistance in chronic obstructive pulmonary disease decreased 25% below normal levels and that in congestive heart failure increased more than 80% above normal levels, renal vascular resistance increased in both conditions (0.41, 0.60, and 0.20 mm Hg * ml-. min '. 1.73 m2 in chronic obstructive pulmonary disease patients, congestive heart failure patients, and normal subjects, respectively). It is, therefore, clear that patients with chronic obstructive pulmonary disease constrict their renal vascular bed, although they have an overall systemic vasodilatation.
Thus, an identical neurohumoral response and a similar retention of salt and water occurs in these two conditions with a fundamental difference in the hemodynamics. The common factor appears to be a tendency "threatened" in congestive heart failure because of low cardiac output and in chronic obstructive pulmonary disease because of a decrease in systemic vascular resistance. A low, or threatened, arterial blood pressure evokes a reflex increase in sympathetic activity through the baroreceptors and activation of the renin-angiotensin-aldosterone system through the juxtaglomerular cells. Systemic vascular resistance is low in patients with chronic obstructive pulmonary disease because of retained carbon dioxide, which is a potent systemic vasodilator.34 This also explains why edema seldom occurs in patients with chronic obstructive pulmonary disease in the absence of hypercapnia.6'35
Direct Effects of Hypoxia and Hypercapnia
Chronic hypoxia by itself does not cause edema in experimental animals,36 in humans at moderate altitude,37 or in patients with congenital cyanotic heart disease or interstitial pulmonary fibrosis,5,7 conditions in which hypoxia often is severe. Moderately severe acute hypoxia (Pao2, 50 mm Hg) increases renal plasma flow, sodium retention, and urine flow in normal subjects. 38 Fishman et aP25 found that acute hypoxia promoted sodium excretion in patients with chronic obstructive pulmonary disease and concluded that hypoxia was not directly responsible for the edema. Kilburn and Dow-e1139 also found a similar effect of moderate hypoxia in patients with chronic obstructive pulmonary disease who were recovering from acute respiratory failure, but with severe hypoxia (Pao2, <40 mm Hg) sodium retention occurred. Our studies at extreme altitudes (6,000 m) suggest that chronic severe hypoxia increases plasma norepinephrine and aldosterone but suppresses renin activity and causes salt and water retention in humans.4M The direct effects of hypercapnia also are controversial. Aber and Bishop26 were unable to find a consistent relation between renal blood flow and hypercapnia. However, others have shown that hypercapnia can directly decrease renal blood flow at Paco2 levels above 65 mm Hg.39 Such high levels of arterial Paco2 occasionally are seen in patients with chronic obstructive pulmonary disease and were found in three of our patients. Hypercapnia may mediate norepinephrine releasethrough direct central stimulation of the sympathetic nervous system41"42 as well as reflexly through the baroreceptors after vasodilation. Elevated Paco2 also may retain sodium through the Na-H exchange in the renal tubules.43 In dogs, combined acute hypoxemia and hypercapnia causes a decrease in systemic vascular resistance but increases in cardiac output and blood pressure. This is accompanied by an increase in catecholamines, activation of renin and aldosterone, and decreases in effective renal plasma flow, glomerular filtration rate, and decrease in urinary sodium excretion."445 Measurements During Recovery When the patients were clinically improved, arterial Pco2 decreased, and this was accompanied by a significant increase in systemic vascular resistance. Arterial pressure had increased but had not returned to normal. Increased renal plasma flow and glomerular filtration rate had led to a decrease in retention of sodium and water, but again not to normal. The hormonal changes were variable and limited, the most significant change being a reduction in plasma atrial natriuretic peptide, toward low arterial blood pressure. Blood pressure is which would be expected from the reduction in atrial pressures. Although the plasma norepinephrine did not, on the average, decrease significantly, the increase in renal plasma flow would suggest a decrease in renal sympathetic activity. On the other hand, the decrease in Paco2 and in plasma atrial natriuretic peptide might have permitted the general vasoconstrictive effects of high plasma norepinephrine, angiotensin, and vasopressin to raise the systemic vascular resistance to normal.
Study Limitations
One of the major limitations of this study was that it was conducted with patients who were receiving treatment and in whom other confounding variables such as sodium intake were not controlled before hospital admission. It is difficult to find untreated patients with chronic obstructive pulmonary disease with salt and water retention. Other variables often are impossible to control in such a clinical setting. We therefore took the next best approach and did not alter drug therapy throughout the hospital stay of these patients. Nevertheless, the effects of bed rest, sodium intake, and diuretics cannot be ignored. These may have influenced fluid balance and hormone levels during recovery. The variable effects of treatment on their hormonal profile may be the result of a number of opposing influences, including the stress of respiratory failure, effects of diuretics, sodium intake, hypoxia and hypercapnia, and the feedback control of renin by variations in the extracellular volume.
General Conclusions
Our findings enable us to reconstruct the possible sequence of events leading to edema in chronic obstructive pulmonary disease. Respiratory infection in patients with chronic obstructive pulmonary disease increases arterial hypoxia and leads to carbon dioxide retention. Hypercapnia is a powerful vasodilator that decreases systemic vascular resistance34 and threatens arterial blood pressure. This inactivates the arterial baroreceptors, leading to reflex increase in norepinephrine and stimulation of the renin-angiotensin-aldosterone system, in the same way as in low cardiac output states.34 An increase in Paco2 also may contribute to central sympathetic stimulation and release of catecholamines.41,42 The greatly increased sympathetic activity reduces renal blood flow and, to a lesser extent, glomerular filtration and may contribute to nonosmotic release of vasopressin.'8 At very high levels, hypercapnia also may directly reduce renal blood flow.39 The net effect is retention of sodium and water. Superimposed on this mechanism are the influences of the renin-angiotensin-aldosterone system and vasopressin, further favoring the retention of salt and water. The expanded extracellular volume increases intracardiac pressures. The resulting atrial distension leads to an increase in plasma atrial natriuretic peptide secretion with vasodilator properties that would be expected to further reduce systemic vascular resistance. The greatly expanded blood volume, however, helps to maintain the arterial pressure, and the negative feedback control explains the great variability of the plasma renin activity and aldosterone levels seen in these patients. The increase in atrial natriuretic peptide also has a negative effect on aldosterone secretion. These consistent with the theory15"6 that the congestive cardiac failure syndrome is the result of the neurohumoral response that arises from the activation of mechanisms that maintain arterial pressure.
